The shares of Moderna Inc rose sharply by more than 15% during trading today, Wednesday, after the company announced strong financial results for the second quarter of this year.

The major pharmaceutical and technology company announced that its revenues increased by 9% to reach $4.75 billion, with earnings per share reaching $5.24 during the second quarter of this year, exceeding market expectations, which caused the company's stock MRNA to rise strongly in trading.

During today's trading in the US stock market, Moderna's MRNA stock rose by 16.80% and recorded about $187.82, the highest level since last March.

However, with the company's stock benefiting from the announcement of the financial statements for the second quarter of this year, Moderna's stock may continue its strong gains and approach its highest levels since mid-January near $200 per share.